Deutsche Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.61M Sell
195,196
-8,926
-4% -$257K ﹤0.01% 1189
2025
Q1
$6.85M Sell
204,122
-7,192
-3% -$241K ﹤0.01% 1125
2024
Q4
$10.8M Sell
211,314
-4,803
-2% -$246K ﹤0.01% 998
2024
Q3
$11M Buy
216,117
+12,228
+6% +$625K ﹤0.01% 984
2024
Q2
$9.13M Buy
203,889
+134,282
+193% +$6.01M ﹤0.01% 1027
2024
Q1
$3.26M Sell
69,607
-10,820
-13% -$506K ﹤0.01% 1429
2023
Q4
$2.86M Buy
80,427
+50,217
+166% +$1.79M ﹤0.01% 1476
2023
Q3
$898K Buy
30,210
+7,125
+31% +$212K ﹤0.01% 1768
2023
Q2
$416K Sell
23,085
-15,234
-40% -$275K ﹤0.01% 2453
2023
Q1
$615K Buy
38,319
+9,062
+31% +$146K ﹤0.01% 2374
2022
Q4
$535K Buy
29,257
+7,736
+36% +$142K ﹤0.01% 2408
2022
Q3
$423K Sell
21,521
-3,442
-14% -$67.7K ﹤0.01% 2456
2022
Q2
$466K Sell
24,963
-1,330
-5% -$24.8K ﹤0.01% 2633
2022
Q1
$577K Sell
26,293
-2,978
-10% -$65.4K ﹤0.01% 2649
2021
Q4
$832K Sell
29,271
-60,785
-67% -$1.73M ﹤0.01% 2534
2021
Q3
$1.9M Buy
90,056
+970
+1% +$20.4K ﹤0.01% 2134
2021
Q2
$1.68M Buy
89,086
+4,120
+5% +$77.6K ﹤0.01% 2385
2021
Q1
$1.3M Buy
84,966
+64,495
+315% +$985K ﹤0.01% 2493
2020
Q4
$289K Buy
20,471
+5,044
+33% +$71.2K ﹤0.01% 3209
2020
Q3
$242K Buy
15,427
+1,306
+9% +$20.5K ﹤0.01% 3083
2020
Q2
$247K Buy
14,121
+10,323
+272% +$181K ﹤0.01% 2997
2020
Q1
$56K Sell
3,798
-222
-6% -$3.27K ﹤0.01% 3419
2019
Q4
$100K Buy
4,020
+919
+30% +$22.9K ﹤0.01% 3507
2019
Q3
$45K Sell
3,101
-177
-5% -$2.57K ﹤0.01% 3866
2019
Q2
$81K Sell
3,278
-6,068
-65% -$150K ﹤0.01% 4155
2019
Q1
$210K Buy
9,346
+2,500
+37% +$56.2K ﹤0.01% 3886
2018
Q4
$203K Sell
6,846
-8,914
-57% -$264K ﹤0.01% 3772
2018
Q3
$451K Buy
+15,760
New +$451K ﹤0.01% 3783